Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.25M Sell
15,372
-2,285
-13% -$174K 0.06% 358
2017
Q1
$1.23M Buy
+17,657
New +$1.22M 0.06% 307
2016
Q3
Sell
-34,449
Closed -$2.37M 793
2016
Q2
$2.37M Buy
+34,449
New +$2.41M 0.14% 200
2016
Q1
Sell
-9,036
Closed -$681K 1046
2015
Q4
$681K Buy
9,036
+1,187
+15% +$85.8K 0.05% 389
2015
Q3
$510K Sell
7,849
-18,711
-70% -$1.24M 0.03% 462
2015
Q2
$1.71M Buy
+26,560
New +$1.79M 0.1% 237
2014
Q3
Sell
-4,539
Closed -$243K 971
2014
Q2
$243K Buy
+4,539
New +$234K 0.02% 605

Other funds holding STE

Airain Ltd's STE Position: Q2 2017 in Review

Airain Ltd reduced its Steris (STE) stake by 13% in Q2 2017, selling an estimated $174K and leaving 15,372 shares worth $1.25M. The position accounts for 0.06% of the portfolio, ranked #358.

Airain Ltd first reported a position in STE in Q2 2014 and has held it in 7 quarters since. The position peaked at $2.37M in Q2 2016. 297 funds tracked by Wall St. Rank hold STE as of Q2 2017.

  • Airain Ltd held 15,372 shares of Steris worth $1.25M as of Q2 2017.
  • Airain Ltd sold 2,285 Steris shares in Q2 2017, an estimated $174K.
  • Steris made up 0.06% of Airain Ltd's portfolio in Q2 2017, its #358 holding.
  • Airain Ltd first reported a position in Steris in Q2 2014 and has held it in 7 quarters since.
  • Airain Ltd's Steris position peaked at $2.37M in Q2 2016.
  • 297 funds tracked by Wall St. Rank held Steris as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.